BTI Is My Largest Dividend Payer. I'm Testing Whether It Deserves That Weight.

British American Tobacco (BTI) is up roughly 34% since I bought it in my Balanced IRA. It yields about 6% at the October 12 close of $55.62, and the board's latest raise stretched its record to 27 straight years of increases in sterling.

That raise was 2%. So was the one before it, and the one before that.

A winning position with a long dividend record sounds like an easy hold, and I don't think it's that simple.

How much of my retirement income should ride on a dividend growing 2% a year?

That question gets sharper every month. I turn 59 1/2 in early 2027, when these dividends stop being a spreadsheet number and turn into cash I can actually spend. BTI sits at 4.3% of the Balanced IRA, my largest individual Dividend Growth Total Return [DGTR] position, and I hold a smaller 1.7% stake in my Primary taxable account that's up about 10%.

BTI is not a hypothetical position or a stock I'm screening for a potential purchase. It's an investment I already own, and one that contributes more dividend income than any other individual holding in this sleeve.

The question is whether that contribution justifies the capital I've committed to it. To answer it, I'll measure how dependent the sleeve is on BTI's income, separate the board's dividend-growth record from currency effects, reconcile reported cash coverage against the Canadian settlement, and apply my position-sizing rules. The result will determine what I need to see before keeping, reducing, or reconsidering its role.